SCOP Search:   
        by sunid, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: All beta proteins (24004)
(-)
Fold: Acid proteases (1120)
(-)
Superfamily: Acid proteases (1120)
(-)
Family: Pepsin-like (505)
(-)
Protein domain: Acid protease (44)
(-)
Baker's yeast (Saccharomyces cerevisiae), proteinase A [TaxId: 4932] (11)
1DP5A:THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT INHIBITOR
1DPJA:THE STRUCTURE OF PROTEINASE A COMPLEXED WITH IA3 PEPTIDE INHIBITOR
1FMUA:STRUCTURE OF NATIVE PROTEINASE A IN P3221 SPACE GROUP.
1FMXA:; B:STRUCTURE OF NATIVE PROTEINASE A IN THE SPACE GROUP P21
1FQ4A:CRYSTAL STRUCTURE OF A COMPLEX BETWEEN HYDROXYETHYLENE INHIBITOR CP-108,420 AND YEAST ASPARTIC PROTEINASE A
1FQ5A:X-RAY STRUCTURE OF A CYCLIC STATINE INHIBITOR PD-129,541 BOUND TO YEAST PROTEINASE A
1FQ6A:X-RAY STRUCTURE OF GLYCOL INHIBITOR PD-133,450 BOUND TO SACCHAROPEPSIN
1FQ7A:X-RAY STRUCTURE OF INHIBITOR CP-72,647 BOUND TO SACCHAROPEPSIN
1FQ8A:X-RAY STRUCTURE OF DIFLUOROSTATINE INHIBITOR CP81,198 BOUND TO SACCHAROPEPSIN
1G0VA:THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT, MVV
2JXRA:STRUCTURE OF YEAST PROTEINASE A
(-)
Bread mold (Rhizopus chinensis) [TaxId: 4843] (8)
1UH7A:CRYSTAL STRUCTURE OF RHIZOPUSPEPSIN AT PH 4.6
1UH8A:CRYSTAL STRUCTURE OF RHIZOPUSPEPSIN AT PH 8.0
1UH9A:CRYSTAL STRUCTURE OF RHIZOPUSPEPSIN AT PH 7.0
2APRA:STRUCTURE AND REFINEMENT AT 1.8 ANGSTROMS RESOLUTION OF THE ASPARTIC PROTEINASE FROM RHIZOPUS CHINENSIS
3APRE:BINDING OF A REDUCED PEPTIDE INHIBITOR TO THE ASPARTIC PROTEINASE FROM RHIZOPUS CHINENSIS. IMPLICATIONS FOR A MECHANISM OF ACTION
4APRE:STRUCTURES OF COMPLEXES OF RHIZOPUSPEPSIN WITH PEPSTATIN AND OTHER STATINE-CONTAINING INHIBITORS
5APRE:STRUCTURES OF COMPLEXES OF RHIZOPUSPEPSIN WITH PEPSTATIN AND OTHER STATINE-CONTAINING INHIBITORS
6APRE:STRUCTURES OF COMPLEXES OF RHIZOPUSPEPSIN WITH PEPSTATIN AND OTHER STATINE-CONTAINING INHIBITORS
(-)
Fungus (Aspergillus oryzae) [TaxId: 5062] (2)
1IZDA:CRYSTAL STRUCTURE OF ASPERGILLUS ORYZAE ASPARTIC PROTEINASE
1IZEA:CRYSTAL STRUCTURE OF ASPERGILLUS ORYZAE ASPARTIC PROTEINASE COMPLEXED WITH PEPSTATIN
(-)
Fungus (Aspergillus phoenicis), aspergillopepsin [TaxId: 5063] (1)
1IBQA:; B:ASPERGILLOPEPSIN FROM ASPERGILLUS PHOENICIS
(-)
Fungus (Penicillium janthinellum), penicillopepsin [TaxId: 5079] (14)
1APTE:CRYSTALLOGRAPHIC ANALYSIS OF A PEPSTATIN ANALOGUE BINDING TO THE ASPARTYL PROTEINASE PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION
1APUE:CRYSTALLOGRAPHIC ANALYSIS OF A PEPSTATIN ANALOGUE BINDING TO THE ASPARTYL PROTEINASE PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION
1APVE:CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING PEPTIDES
1APWE:CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING PEPTIDES
1BXOA:ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL CYCLO[(2S)-2-[[(1R)-1-(N-(L-N-(3-METHYLBUTANOYL)VALYL-L-ASPARTYL)AMINO)-3-METHYLBUT YL] HYDROXYPHOSPHINYLOXY]-3-(3-AMINOMETHYL) PHENYLPROPANOATE
1BXQA:ACID PROTEINASE (PENICILLOPEPSIN) COMPLEX WITH PHOSPHONATE INHIBITOR.
1PPKE:CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHOROUS-CONTAINING PEPTIDE ANALOGUES
1PPLE:CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION-STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHORUS-CONTAINING PEPTIDE ANALOGUES
1PPME:CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION-STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHORUS-CONTAINING PEPTIDE ANALOGUES
2WEAA:ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL[CYCLO-7[(2R)-((N-VALYL) AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY) PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT
2WEBA:ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-FORMYL)-L-VALYL)AMINO-2-(2-NAPHTHYL)ETHYL)HYDROXYPHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT
2WECA:ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-(1-NAPHTHALENEACETYL))-L-VALYL)AMINOMETHYL)HYDROXY PHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT
2WEDA:ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE MACROCYCLIC INHIBITOR:METHYL[CYCLO-7[(2R)-((N-VALYL)AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY)PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT
3APPA:STRUCTURE AND REFINEMENT OF PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION
(-)
Irpex lacteus (Polyporus tulipiferae), Polyporopepsin [TaxId: 5319] (1)
1WKRA:CRYSTAL STRUCTURE OF ASPARTIC PROTEINASE FROM IRPEX LACTEUS
(-)
Rhizomucor miehei [TaxId: 4839] (2)
2ASIA:ASPARTIC PROTEINASE
2RMPA:RMP-PEPSTATIN A COMPLEX
(-)
Yeast (Candida albicans) [TaxId: 5476] (4)
1EAGA:SECRETED ASPARTIC PROTEINASE (SAP2) FROM CANDIDA ALBICANS COMPLEXED WITH A70450
1ZAPA:SECRETED ASPARTIC PROTEASE FROM C. ALBICANS
3PVKA:SECRETED ASPARTIC PROTEASE 2 IN COMPLEX WITH BENZAMIDINE
3Q70A:SECRETED ASPARTIC PROTEASE IN COMPLEX WITH RITONAVIR
(-)
Yeast (Candida tropicalis) [TaxId: 5482] (1)
1J71A:STRUCTURE OF THE EXTRACELLULAR ASPARTIC PROTEINASE FROM CANDIDA TROPICALIS YEAST.
(-)
Protein domain: automated matches (64)
(-)
Camel (Camelus dromedarius) [TaxId: 9838] (1)
4AA9A:CAMEL CHYMOSIN AT 1.6A RESOLUTION
(-)
Cryphonectria parasitica [TaxId: 5116] (21)
2JJIA:ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR.
2JJJA:ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR.
2V00A:X-RAY CRYSTAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH COMPOUND 1
2VS2A:NEUTRON DIFFRACTION STRUCTURE OF ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR.
3LZYA:CRYSTAL STRUCTURE OF ENDOTHIAPESIN IN COMPLEX WITH XENON
3PB5A:ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT
3PBDA:ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT
3PBZA:ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT
3PCWA:ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT
3PCZA:ENDOTHIAPEPSIN IN COMPLEX WITH BENZAMIDINE
3PGIA:ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT
3PI0A:ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT
3PLDA:ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT
3PLLA:ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT
3PM4A:ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT
3PMUA:ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT
3PMYA:ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT
3PRSA:ENDOTHIAPEPSIN IN COMPLEX WITH RITONAVIR
3PSYA:ENDOTHIAPEPSIN IN COMPLEX WITH AN INHIBITOR BASED ON THE GEWALD REACTION
3PWWA:ENDOTHIAPEPSIN IN COMPLEX WITH SAQUINAVIR
3Q6YA:ENDOTHIAPEPSIN IN COMPLEX WITH A PYRROLIDINE BASED INHIBITOR
(-)
Human (Homo sapiens) [TaxId: 9606] (38)
1TZSA:CRYSTAL STRUCTURE OF AN ACTIVATION INTERMEDIATE OF CATHEPSIN E
1YM2A:; B:; C:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH NVP-AUR200
1YM4A:; B:; C:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH NVP-AMK640
2VA5A:X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 8C
2VA6A:X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 24
2VA7A:X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 27
2VIEA:HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-1-BENZYL-2-HYDROXY-3-((1,1,5-TRIMETHYLHEXYL)AMINO)PROPYL)-3-(ETHYLAMINO)-5-(2-OXOPYRROLIDIN-1-YL)BENZAMIDE
2VIJA:HUMAN BACE-1 IN COMPLEX WITH 3-(1,1-DIOXIDOTETRAHYDRO-2H-1, 2-THIAZIN-2-YL)-5-(ETHYLAMINO)-N-((1S,2R)-2-HYDROXY-1-( PHENYLMETHYL)-3-(1,2,3,4-TETRAHYDRO-1-NAPHTHALENYLAMINO) PROPYL)BENZAMIDE
2VIYA:HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-( CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-(PENTYLSULFONYL)BENZAMIDE
2VIZA:HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-( CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-(2-OXO-1-PYRROLIDINYL)-5-(PROPYLOXY) BENZAMIDE
2VJ6A:HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-( CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-(ETHYLAMINO)-5-(2-OXO-1-PYRROLIDINYL)BENZAMIDE
2VJ7A:HUMAN BACE-1 IN COMPLEX WITH 3-(ETHYLAMINO)-N-((1S,2R)-2-HYDROXY-1-(PHENYLMETHYL)-3-(((3-(TRIFLUOROMETHYL)PHENYL) METHYL)AMINO)PROPYL)-5-(2-OXO-1-PYRROLIDINYL)BENZAMIDE
2VJ9A:HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(CYCLOHEXYLAMINO)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-3-(ETHYLAMINO)-5-(2-OXO-1-PYRROLIDINYL)BENZAMIDE
2VNMA:HUMAN BACE-1 IN COMPLEX WITH 3-(1,1-DIOXIDOTETRAHYDRO-2H-1, 2-THIAZIN-2-YL)-5-(ETHYLAMINO)-N-((1S,2R)-2-HYDROXY-1-( PHENYLMETHYL)-3-(((3-(TRIFLUOROMETHYL)PHENYL)METHYL)AMINO) PROPYL)BENZAMIDE
2VNNA:HUMAN BACE-1 IN COMPLEX WITH 7-ETHYL-N-((1S,2R)-2-HYDROXY-1-(PHENYLMETHYL)-3-(((3-(TRIFLUOROMETHYL)PHENYL)METHYL)AMINO) PROPYL)-1-METHYL-3,4-DIHYDRO-1H-(1,2,5)THIADIAZEPINO(3,4,5-HI)INDOLE-9-CARBOXAMIDE 2,2-DIOXIDE
2WEZA:HUMAN BACE-1 IN COMPLEX WITH 1-ETHYL-N-((1S,2R)-2-HYDROXY-3-(((3-(METHYLOXY)PHENYL)METHYL)AMINO)-1-(PHENYLMETHYL) PROPYL)-4-(2-OXO-1-PYRROLIDINYL)-1H-INDOLE-6-CARBOXAMIDE
2WF0A:HUMAN BACE-1 IN COMPLEX WITH 4-ETHYL-N-((1S,2R)-2-HYDROXY-1-(PHENYLMETHYL)-3-(((3-(TRIFLUOROMETHYL)PHENYL)METHYL)AMINO) PROPYL)-8-(2-OXO-1-PYRROLIDINYL)-6-QUINOLINECARBOXAMIDE
2WF1A:HUMAN BACE-1 IN COMPLEX WITH 7-ETHYL-N-((1S,2R)-2-HYDROXY-3-(((3-(METHYLOXY)PHENYL(METHYL)AMINO)-1-(PHENYLMETHYL) PROPYL)-1-METHYL-3,4-DIHYDRO-1H-(1,2,5)THIADIAZEPINO(3,4,5-HI)INDOLE-9-CARBOXAMIDE 2,2-DIOXIDE
2WF2A:HUMAN BACE-1 IN COMPLEX WITH 8-ETHYL-N-((1S,2R)-2-HYDROXY-3-(((3-(METHYLOXY)PHENYL)METHYL)AMINO)-1-(PHENYLMETHYL) PROPYL)-1-METHYL-3,4,7,8-TETRAHYDRO-1H,6H-(1,2,5) THIADIAZEPINO(5,4,3-DE)QUINOXALINE-10-CARBOXAMIDE 2,2-DIOXIDE
2WF3A:HUMAN BACE-1 IN COMPLEX WITH 6-(ETHYLAMINO)-N-((1S,2R)-2-HYDROXY-3-(((3-(METHYLOXY)PHENYL)METHYL)AMINO)-1-(PHENYLMETHYL)PROPYL)-1-METHYL-1, 3,4,5-TETRAHYDRO-2,1-BENZOTHIAZEPINE-8-CARBOXAMIDE 2,2-DIOXIDE
2WF4A:HUMAN BACE-1 IN COMPLEX WITH 6-ETHYL-1-METHYL-N-((1S)-2-OXO-1-(PHENYLMETHYL)-3-(TETRAHYDRO-2H-PYRAN-4-YLAMINO)PROPYL)-1,3,4,6-TETRAHYDRO(1,2)THIAZEPINO(5,4,3-CD)INDOLE-8-CARBOXAMIDE 2,2-DIOXIDE
2WJOA:HUMAN BACE (BETA SECRETASE) IN COMPLEX WITH CYCLOHEXANECARBOXYLIC ACID (2-(2-AM INO-6-PHENOXY-4H-QUINAZOLIN-3-YL)-2-CYCLOHEXYL-ETHYL)-AMIDE
2XFIA:HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-( CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-((METHYLSULFONYL)(PHENYL)AMINO) BENZAMIDE
2XFJA:HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-( CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-(ETHYLAMINO)-5-(2-OXO-1-PYRROLIDINYL)BENZAMIDE
2XFKA:HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-( CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-(ETHYLAMINO)-5-((METHYLSULFONYL)( PHENYL)AMINO)BENZAMIDE
3BRAA:BACE-1 COMPLEXED WITH COMPOUND 1
3BUFA:BACE-1 COMPLEXED WITH COMPOUND 2
3BUGA:BACE-1 COMPLEXED WITH COMPOUND 3
3BUHA:BACE-1 COMPLEXED WITH COMPOUND 4
3CKPA:; B:; C:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH INHIBITOR
3CKRA:; B:; C:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH INHIBITOR
3DM6A:; B:; C:BETA-SECRETASE 1 COMPLEXED WITH STATINE-BASED INHIBITOR
3H0BA:; B:; C:DISCOVERY OF AMINOHETEROCYCLES AS A NOVEL BETA-SECRETASE INHIBITOR CLASS
3ZMGA:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND
3ZOVA:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND
4B1CA:NEW AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM RATIONAL DESIGN TO AB-LOWERING IN BRAIN
4BEKA:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND
4BFDA:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND
(-)
Yeast (Candida albicans) [TaxId: 5476] (4)
2H6SA:SECRETED ASPARTIC PROTEINASE (SAP) 3 FROM CANDIDA ALBICANS
2H6TA:SECRETED ASPARTIC PROTEINASE (SAP) 3 FROM CANDIDA ALBICANS COMPLEXED WITH PEPSTATIN A
2QZWA:; B:SECRETED ASPARTIC PROTEINASE (SAP) 1 FROM CANDIDA ALBICANS
2QZXA:; B:SECRETED ASPARTIC PROTEINASE (SAP) 5 FROM CANDIDA ALBICANS
(-)
Protein domain: beta-secretase (memapsin) (237)
(-)
Human (Homo sapiens) [TaxId: 9606] (237)
1FKNA:; B:STRUCTURE OF BETA-SECRETASE COMPLEXED WITH INHIBITOR
1M4HA:; B:CRYSTAL STRUCTURE OF BETA-SECRETASE COMPLEXED WITH INHIBITOR OM00-3
1SGZA:; B:; C:; D:CRYSTAL STRUCTURE OF UNBOUND BETA-SECRETASE CATALYTIC DOMAIN.
1TQFA:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR
1W50A:APO STRUCTURE OF BACE (BETA SECRETASE)
1W51A:BACE (BETA SECRETASE) IN COMPLEX WITH A NANOMOLAR NON-PEPTIDIC INHIBITOR
1XN2A:; B:; C:; D:NEW SUBSTRATE BINDING POCKETS FOR BETA-SECRETASE.
1XN3A:; B:; C:; D:CRYSTAL STRUCTURE OF BETA-SECRETASE BOUND TO A LONG INHIBITOR WITH ADDITIONAL UPSTREAM RESIDUES.
1XS7D:CRYSTAL STRUCTURE OF A CYCLOAMIDE-URETHANE-DERIVED NOVEL INHIBITOR BOUND TO HUMAN BRAIN MEMAPSIN 2 (BETA-SECRETASE).
2B8LA:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR
2B8VA:CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE COMPLEXED WITH L-L000430,469
2F3EA:; B:; C:CRYSTAL STRUCTURE OF THE BACE COMPLEX WITH AXQ093, A MACROCYCLIC INHIBITOR
2F3FA:; B:; C:CRYSTAL STRUCTURE OF THE BACE COMPLEX WITH BDF488, A MACROCYCLIC INHIBITOR
2FDPA:; B:; C:CRYSTAL STRUCTURE OF BETA-SECRETASE COMPLEXED WITH AN AMINO-ETHYLENE INHIBITOR
2G94A:; B:; C:; D:CRYSTAL STRUCTURE OF BETA-SECRETASE BOUND TO A POTENT AND HIGHLY SELECTIVE INHIBITOR.
2HIZA:61P-385; B:61P-385; C:61P-385CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE (BACE) IN THE PRESENCE OF AN INHIBITOR
2HM1A:CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE (BACE) IN THE PRESENCE OF AN INHIBITOR (2)
2IQGA:CRYSTAL STRUCTURE OF HYDROXYETHYL SECONDARY AMINE-BASED PEPTIDOMIMETIC INHIBITOR OF HUMAN BETA-SECRETASE (BACE)
2IRZA:CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE COMPLEXED WITH INHIBITOR
2IS0A:CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE COMPLEXED WITH INHIBITOR
2NTRA:CRYSTAL STRUCTURE OF HUMAN BACE-1 BOUND TO INHIBITOR
2OAHA:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR
2OF0A:X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 5
2OHKA:X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH 1-AMINO-ISOQUINOLINE
2OHLA:X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH 2-AMINOQUINOLINE
2OHMA:X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH N~3~-BENZYLPYRIDINE-2,3-DIAMINE
2OHNA:X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH 4-(4-FLUOROBENZYL)PIPERIDINE
2OHPA:X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 3
2OHQA:X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 4
2OHRA:X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 6A
2OHSA:X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 6B
2OHTA:X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 7
2OHUA:X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 8B
2P4JA:; B:; C:; D:CRYSTAL STRUCTURE OF BETA-SECRETASE BOND TO AN INHIBITOR WITH ISOPHTHALAMIDE DERIVATIVES AT P2-P3
2P83A:61P-385; B:61P-385; C:61P-385POTENT AND SELECTIVE ISOPHTHALAMIDE S2 HYDROXYETHYLAMINE INHIBITOR OF BACE1
2P8HA:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR
2PH6A:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR
2PH8A:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR
2Q11A:; B:; C:STRUCTURE OF BACE COMPLEXED TO COMPOUND 1
2Q15A:STRUCTURE OF BACE COMPLEXED TO COMPOUND 3A
2QK5A:; B:STRUCTURE OF BACE1 BOUND TO SCH626485
2QMDA:; B:STRUCTURE OF BACE BOUND TO SCH722924
2QMFA:; B:STRUCTURE OF BACE BOUND TO SCH735310
2QMGA:; B:STRUCTURE OF BACE BOUND TO SCH745966
2QP8A:; B:STRUCTURE OF BACE BOUND TO SCH734723
2QU2A:BACE1 WITH COMPOUND 1
2QU3A:BACE1 WITH COMPOUND 2
2QZKA:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH I21
2QZLA:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH IXS
2VKMA:; B:; C:; D:CRYSTAL STRUCTURE OF GRL-8234 BOUND TO BACE (BETA-SECRETASE)
2ZDZA:X-RAY STRUCTURE OF BACE-1 IN COMPLEX WITH COMPOUND 3.B.10
2ZE1A:X-RAY STRUCTURE OF BACE-1 IN COMPLEX WITH COMPOUND 6G
2ZHRA:; B:CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH OM99-2 AT PH 5.0
2ZHSA:CRYSTAL STRUCTURE OF BACE1 AT PH 4.0
2ZHTA:CRYSTAL STRUCTURE OF BACE1 AT PH 4.5
2ZHUA:CRYSTAL STRUCTURE OF BACE1 AT PH 5.0
2ZHVA:CRYSTAL STRUCTURE OF BACE1 AT PH 7.0
2ZJHA:CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-(1-BENZYL-PIPERIDIN-4-YL)-4-MERCAPTO-BUTYRAMIDE
2ZJIA:CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-[1-(2,6-DIMETHOXY-BENZYL)-PIPERIDIN-4-YL]-4-MERCAPTO-BUTYRAMIDE
2ZJJA:CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(4-FLUORO-BENZYL)-PIPERAZINE-2-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE
2ZJKA:; B:; C:CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(4-FLUORO-BENZYL)-PIPERAZINE-2-CARBOXYLIC ACID(3-MERCAPTO-PROPYL)-AMIDE
2ZJLA:CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-[1-(5-BROMO-2,3-DIMETHOXY-BENZYL)-PIPERIDIN-4-YL]-4-MERCAPTO-BUTYRAMIDE
2ZJMA:CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-[1-(5-CHLORO-2-ISOPROPOXY-3-METHOXY-BENZYL)-PIPERIDIN-4-YL]-2-(4-SULFAMOYL-PHENOXY)-ACETAMIDE
2ZJNA:CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-[1-(5-CHLORO-2-ISOPROPOXY-3-METHOXY-BENZYL)-PIPERIDIN-4-YL]-2-(2-METHYL-4-SULFAMOYL-PHENOXY)-ACETAMIDE
3CIBA:; B:STRUCTURE OF BACE BOUND TO SCH727596
3CICA:; B:STRUCTURE OF BACE BOUND TO SCH709583
3CIDA:; B:STRUCTURE OF BACE BOUND TO SCH726222
3DUYA:; B:; C:CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE IN COMPLEX WITH NVP-AFJ144
3DV1A:; B:; C:CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE IN COMPLEX WITH NVP-ARV999
3DV5A:; B:; C:CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE IN COMPLEX WITH NVP-BAV544
3EXOA:CRYSTAL STRUCTURE OF BACE1 BOUND TO INHIBITOR
3FKTA:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH SPIROPIPERDINE IMINOHYDANTOIN INHIBITOR
3HVGA:; B:; C:STRUCTURE OF BACE (BETA SECRETASE) IN COMPLEX WITH EV0
3HW1A:; B:; C:STRUCTURE OF BACE (BETA SECRETASE) IN COMPLEX WITH LIGAND EV2
3I25A:; B:; C:POTENT BETA-SECRETASE 1 HYDROXYETHYLENE INHIBITOR
3IGBA:BACE-1 WITH COMPOUND 3
3IN3A:BACE1 WITH COMPOUND 30
3IN4A:BACE1 WITH COMPOUND 38
3INDA:BACE1 WITH THE AMINOHYDANTOIN COMPOUND 29
3INEA:BACE1 WITH THE AMINOHYDANTOIN COMPOUND S-34
3INFA:BACE1 WITH THE AMINOHYDANTOIN COMPOUND 37
3INHA:BACE1 WITH THE AMINOHYDANTOIN COMPOUND R-58
3IVHA:DESIGN AND SYNTHESIS OF POTENT BACE-1 INHIBITORS WITH CELLULAR ACTIVITY: STRUCTURE-ACTIVITY RELATIONSHIP OF P1 SUBSTITUENTS
3IVIA:; B:; C:DESIGN AND SYNTHESIS OF POTENT BACE-1 INHIBITORS WITH CELLULAR ACTIVITY: STRUCTURE-ACTIVITY RELATIONSHIP OF P1 SUBSTITUENTS
3IXJA:; B:; C:CRYSTAL STRUCTURE OF BETA-SECRETASE 1 IN COMPLEX WITH SELECTIVE BETA-SECRETASE 1 INHIBITOR
3IXKA:; B:; C:POTENT BETA-SECRETASE 1 INHIBITOR
3K5CA:; B:; C:HUMAN BACE-1 COMPLEX WITH NB-216
3K5DA:; B:; C:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH AHM178
3K5FA:; B:; C:HUMAN BACE-1 COMPLEX WITH AYH011
3K5GA:; B:; C:HUMAN BACE-1 COMPLEX WITH BJC060
3KMXA:; B:STRUCTURE OF BACE BOUND TO SCH346572
3KMYA:; B:STRUCTURE OF BACE BOUND TO SCH12472
3KN0A:; B:STRUCTURE OF BACE BOUND TO SCH708236
3KYRA:; B:; C:BACE-1 IN COMPLEX WITH A NORSTATINE TYPE INHIBITOR
3L38A:BACE1 IN COMPLEX WITH THE AMINOPYRIDINE COMPOUND 44
3L3AA:BACE-1 WITH THE AMINOPYRIDINE COMPOUND 32
3L58A:; B:STRUCTURE OF BACE BOUND TO SCH589432
3L59A:; B:STRUCTURE OF BACE BOUND TO SCH710413
3L5BA:; B:STRUCTURE OF BACE BOUND TO SCH713601
3L5CA:; B:STRUCTURE OF BACE BOUND TO SCH723871
3L5DA:; B:STRUCTURE OF BACE BOUND TO SCH723873
3L5EA:; B:STRUCTURE OF BACE BOUND TO SCH736062
3L5FA:; B:STRUCTURE OF BACE BOUND TO SCH736201
3LHGA:BACE1 IN COMPLEX WITH THE AMINOHYDANTOIN COMPOUND 4G
3LNKA:; B:STRUCTURE OF BACE BOUND TO SCH743813
3MSJA:; B:; C:STRUCTURE OF BACE (BETA SECRETASE) IN COMPLEX WITH INHIBITOR
3MSKA:FRAGMENT BASED DISCOVERY AND OPTIMISATION OF BACE-1 INHIBITORS
3MSLA:FRAGMENT BASED DISCOVERY AND OPTIMISATION OF BACE-1 INHIBITORS
3N4LA:; B:; C:BACE-1 IN COMPLEX WITH ELN380842
3NSHA:; B:; C:BACE-1 IN COMPLEX WITH ELN475957
3OOZA:BACE1 IN COMPLEX WITH THE AMINOHYDANTOIN COMPOUND 102
3PI5A:; B:; C:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH BFG356
3QBHA:; B:; C:STRUCTURE BASED DESIGN, SYNTHESIS AND SAR OF CYCLIC HYDROXYETHYLAMINE (HEA) BACE-1 INHIBITORS
3QI1A:DESIGN AND SYNTHESIS OF HYDROXYETHYLAMINE (HEA) BACE-1 INHIBITORS: PRIME SIDE CHROMANE-CONTAINING INHIBITORS
3R1GB:STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE-BINDING ANTIBODY
3RSVA:STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH (R)-3-(2-AMINO-6-O-TOLYLQUINOLIN-3-YL)-N-((R)-2,2-DIMETHYLTETRAHYDRO-2H-PYRAN-4-YL)-2-METHYLPROPANAMIDE
3RSXA:STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 6-(THIOPHEN-3-YL)QUINOLIN-2-AMINE
3RTHA:STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 6-(2-(3,3-DIMETHYLBUT-1-YNYL)PHENYL)QUINOLIN-2-AMINE
3RTMA:STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 3-(2-AMINOQUINOLIN-3-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE
3RTNA:STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 3-(2-AMINO-6-O-TOLYLQUINOLIN-3-YL)-N-CYCLOHEXYLPROPANAMIDE
3RU1A:STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 3-(2-AMINOQUINOLIN-3-YL)-N-(CYCLOHEXYLMETHYL)PROPANAMIDE
3RVIA:STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH 2-((2-AMINO-6-O-TOLYLQUINOLIN-3-YL)METHYL)-N-(CYCLOHEXYLMETHYL)PENTANAMIDE
3S2OA:FRAGMENT BASED DISCOVERY AND OPTIMISATION OF BACE-1 INHIBITORS
3S7LA:PYRAZOLYL AND THIENYL AMINOHYDANTOINS AS POTENT BACE1 INHIBITORS
3S7MA:PYRAZOLYL AND THIENYL AMINOHYDANTOINS AS POTENT BACE1 INHIBITORS
3TPJA:APO STRUCTURE OF BACE1
3TPPA:CRYSTAL STRUCTURE OF BACE1 COMPLEXED WITH AN INHIBITOR
3TPRA:CRYSTAL STRUCTURE OF BACE1 COMPLEXED WITH AN INHIBITOR
3U6AA:; B:; C:RATIONAL DESIGN AND SYNTHESIS OF AMINOPIPERAZINONES AS BETA SECRETASE (BACE) INHIBITORS
3UDHA:CRYSTAL STRUCTURE OF BACE WITH COMPOUND 1
3UDJA:CRYSTAL STRUCTURE OF BACE WITH COMPOUND 5
3UDKA:CRYSTAL STRUCTURE OF BACE WITH COMPOUND 6
3UDMA:CRYSTAL STRUCTURE OF BACE WITH COMPOUND 8
3UDNA:CRYSTAL STRUCTURE OF BACE WITH COMPOUND 9
3UDPA:CRYSTAL STRUCTURE OF BACE WITH COMPOUND 12
3UDQA:CRYSTAL STRUCTURE OF BACE WITH COMPOUND 13
3UDRA:CRYSTAL STRUCTURE OF BACE WITH COMPOUND 14
3UDYA:CRYSTAL STRUCTURE OF BACE WITH COMPOUND 11
3UFLA:DISCOVERY OF PYRROLIDINE-BASED B-SECRETASE INHIBITORS: LEAD ADVANCEMENT THROUGH CONFORMATIONAL DESIGN FOR MAINTENANCE OF LIGAND BINDING EFFICIENCY
3UQUA:CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR
3UQWA:CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR
3UQXA:CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR
3VEUA:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-AVI326
3VF3A:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BQQ711
3VG1A:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BUR436, DERIVED FROM A SOAKING EXPERIMENT
3VV6A:CRYSTAL STRUCTURE OF BETA SECETASE IN COMPLEX WITH 2-AMINO-3-METHYL-6-((1S, 2R)-2-PHENYLCYCLOPROPYL)PYRIMIDIN-4(3H)-ONE
3VV7A:CRYSTAL STRUCTURE OF BETA SECETASE IN COMPLEX WITH 2-AMINO-6-((1S,2R)-2-(3'-METHOXYBIPHENYL-3-YL)CYCLOPROPYL)-3-METHYLPYRIMIDIN-4(3H)-ONE
3VV8A:CRYSTAL STRUCTURE OF BETA SECETASE IN COMPLEX WITH 2-AMINO-3-METHYL-6-((1S,2R)-2-(3'-METHYLBIPHENYL-4-YL)CYCLOPROPYL)PYRIMIDIN-4(3H)-ONE
3WB4A:CRYSTAL STRUCTURE OF BETA SECETASE IN COMPLEX WITH 2-AMINO-3,6-DIMETHYL-6-(2-PHENYLETHYL)-3,4,5,6-TETRAHYDROPYRIMIDIN-4-ONE
3WB5A:CRYSTAL STRUCTURE OF BETA SECETASE IN COMPLEX WITH (6S)-2-AMINO-3,6-DIMETHYL-6-[(1R,2R)-2-PHENYLCYCLOPROPYL]-3,4,5,6-TETRAHYDROPYRIMIDIN-4-ONE
4ACUA:AMINOIMIDAZOLES AS BACE-1 INHIBITORS. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 14
4ACXA:AMINOIMIDAZOLES AS BACE-1 INHIBITORS. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 23
4AZYA:DESIGN AND SYNTHESIS OF BACE1 INHIBITORS WITH IN VIVO BRAIN REDUCTION OF BETA-AMYLOID PEPTIDES (COMPOUND 10)
4B00A:DESIGN AND SYNTHESIS OF BACE1 INHIBITORS WITH IN VIVO BRAIN REDUCTION OF BETA-AMYLOID PEPTIDES (COMPOUND (R)-41)
4B05A:PRECLINICAL CHARACTERIZATION OF AZD3839, A NOVEL CLINICAL CANDIDATE BACE1 INHIBITOR FOR THE TREATMENT OF ALZHEIMER DISEASE
4B0QA:LEAD GENERATION OF BACE1 INHIBITORS BY COUPLING NON-AMIDINE NEW WARHEADS TO A KNOWN BINDING SCAFFOLD
4B1DA:NEW AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM RATIONAL DESIGN TO AB-LOWERING IN BRAIN
4B1EA:NEW AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM RATIONAL DESIGN TO AB-LOWERING IN BRAIN
4B70A:AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM DE NOVO DESIGN TO AB-LOWERING IN BRAIN
4B72A:AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM DE NOVO DESIGN TO AB-LOWERING IN BRAIN
4B77A:AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM DE NOVO DESIGN TO AB-LOWERING IN BRAIN
4B78A:AMINOIMIDAZOLES AS BACE-1 INHIBITORS: FROM DE NOVO DESIGN TO AB-LOWERING IN BRAIN
4D83A:; B:; C:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BUR436, DERIVED FROM A CO-CRYSTALLIZATION EXPERIMENT
4D85A:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BVI151
4D88A:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BXQ490
4D89A:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BXD552, DERIVED FROM A SOAKING EXPERIMENT
4D8CA:; B:; C:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BXD552, DERIVED FROM A CO-CRYSTALLIZATION EXPERIMENT
4DH6A:STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH (2R)-N-((2S,3R)-1-(BENZO[D][1,3]DIOXOL-5-YL)-3-HYDROXY-4-((S)-6'-NEOPENTYL-3',4'-DIHYDROSPIRO[CYCLOBUTANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YLAMINO) BUTAN-2-YL)-2-METHOXYPROPANAMIDE
4DI2A:; B:; C:CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH HYDROXYETHYLAMINE INHIBITOR 37
4DJUA:; B:STRUCTURE OF BACE BOUND TO 2-IMINO-3-METHYL-5,5-DIPHENYLIMIDAZOLIDIN-4-ONE
4DJVA:; B:STRUCTURE OF BACE BOUND TO 2-IMINO-5-(3'-METHOXY-[1,1'-BIPHENYL]-3-YL)-3-METHYL-5-PHENYLIMIDAZOLIDIN-4-ONE
4DJWA:; B:STRUCTURE OF BACE BOUND TO 2-IMINO-3-METHYL-5-PHENYL-5-(3-(PYRIDIN-3-YL)PHENYL)IMIDAZOLIDIN-4-ONE
4DJXA:; B:STRUCTURE OF BACE BOUND TO 5-(3-(5-CHLOROPYRIDIN-3-YL)PHENYL)-5-CYCLOPROPYL-2-IMINO-3-METHYLIMIDAZOLIDIN-4-ONE
4DJYA:; B:STRUCTURE OF BACE BOUND TO (R)-5-CYCLOPROPYL-2-IMINO-3-METHYL-5-(3-(5-(PROP-1-YN-1-YL)PYRIDIN-3-YL)PHENYL)IMIDAZOLIDIN-4-ONE
4DPFA:BACE-1 IN COMPLEX WITH A HEA-MACROCYCLIC TYPE INHIBITOR
4DPIA:BACE-1 IN COMPLEX WITH HEA-MACROCYCLIC INHIBITOR, MV078512
4DUSA:STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH N-((2S,3R)-1-(4-FLUOROPHENYL)-3-HYDROXY-4-((6'-NEOPENTYL-3',4'-DIHYDROSPIRO[CYCLOBUTANE-1,2'-PYRANO[2,3-B]PYRIDIN]-4'-YL)AMINO) BUTAN-2-YL)ACETAMIDE
4EWOA:DESIGN AND SYNTHESIS OF POTENT HYDROXYETHYLAMINE (HEA) BACE-1 INHIBITORS
4EXGA:DESIGN AND SYNTHESIS OF POTENT HYDROXYETHYLAMINE (HEA) BACE-1 INHIBITORS
4FCOA:CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR
4FM7A:CRYSTAL STRUCTURE OF BACE WITH COMPOUND 14G
4FM8A:CRYSTAL STRUCTURE OF BACE WITH COMPOUND 12A
4FRIA:CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH BIARYLSPIRO AMINOOXAZOLINE 6
4FRJA:CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH AMINOOXAZOLINE XANTHENE 9L
4FRKA:CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH AMINOOXAZOLINE XANTHENE 11A
4FRSA:; B:STRUCTURE OF BACE IN COMPLEX WITH (S)-4-(3-CHLORO-5-(5-(PROP-1-YN-1-YL)PYRIDIN-3-YL)THIOPHEN-2-YL)-1,4-DIMETHYL-6-OXOTETRAHYDROPYRIMIDIN-2(1H)-IMINIUM
4FS4A:; B:STRUCTURE OF BACE BOUND TO (S)-4-(3'-METHOXY-[1,1'-BIPHENYL]-3-YL)-1, 4-DIMETHYL-6-OXOTETRAHYDROPYRIMIDIN-2(1H)-IMINIUM
4FSLA:; B:; D:; E:CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 (BACE-DB-MUT) COMPLEX WITH N-(N-(4- ACETAMIDO-3-CHLORO-5-METHYLBENZYL) CARBAMIMIDOYL)-3-(4- METHOXYPHENYL)-5-METHYL-4-ISOTHIAZOLECARBOXAMIDE
4GIDA:; B:; C:; D:STRUCTURE OF BETA-SECRETASE COMPLEXED WITH INHIBITOR
4GMIA:BACE-1 IN COMPLEX WITH HEA-TYPE MACROCYCLIC INHIBITOR, MV078571
4H1EA:; B:STRUCTURE OF BACE-1 BOUND TO (7AR)-6-BENZOYL-7A-(4-(3-CYANOPHENYL) THIOPHEN-2-YL)-3-METHYL-4-OXOHEXAHYDRO-1H-PYRROLO[3,4-D]PYRIMIDIN-2(3H)-IMINIUM
4H3FA:; B:STRUCTURE OF BACE BOUND TO 3-(5-((7AR)-2-IMINO-6-(6-METHOXYPYRIDIN-2-YL)-3-METHYL-4-OXOOCTAHYDRO-1H-PYRROLO[3,4-D]PYRIMIDIN-7A-YL) THIOPHEN-3-YL)BENZONITRILE
4H3GA:; B:STRUCTURE OF BACE BOUND TO 2-((7AR)-7A-(4-(3-CYANOPHENYL)THIOPHEN-2-YL)-2-IMINO-3-METHYL-4-OXOHEXAHYDRO-1H-PYRROLO[3,4-D]PYRIMIDIN-6(2H)-YL)NICOTINONITRILE
4H3IA:; B:STRUCTURE OF BACE BOUND TO 3-(5-((7AR)-2-IMINO-6-(3-METHOXYPYRIDIN-2-YL)-3-METHYL-4-OXOOCTAHYDRO-1H-PYRROLO[3,4-D]PYRIMIDIN-7A-YL) THIOPHEN-3-YL)BENZONITRILE
4H3JA:; B:STRUCTURE OF BACE BOUND TO 2-FLUORO-5-(5-(2-IMINO-3-METHYL-4-OXO-6-PHENYLOCTAHYDRO-1H-PYRROLO[3,4-D]PYRIMIDIN-7A-YL)THIOPHEN-2-YL) BENZONITRILE
4HA5A:; B:STRUCTURE OF BACE BOUND TO (S)-3-(5-(2-IMINO-1,4-DIMETHYL-6-OXOHEXAHYDROPYRIMIDIN-4-YL)THIOPHEN-3-YL)BENZONITRILE
4HZTA:STRUCTURE-BASED DESIGN OF NOVEL DIHYDROISOQUINOLINE BACE-1 INHIBITORS THAT DO NOT ENGAGE THE CATALYTIC ASPARTATES
4I0DA:DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS
4I0EA:DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS
4I0FA:DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS
4I0GA:DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS
4I0HA:; B:; C:SPR AND STRUCTURAL ANALYSIS YIELD INSIGHT TOWARDS MECHANISM OF INHIBITION OF BACE INHIBITORS.
4I0IA:; B:; C:SPR AND STRUCTURAL ANALYSIS YIELD INSIGHT TOWARDS MECHANISM OF INHIBITION OF BACE INHIBITORS
4I0JA:SPR AND STRUCTURAL ANALYSIS YIELD INSIGHT TOWARDS MECHANISM OF INHIBITION OF BACE INHIBITORS
4I0ZA:STRUCTURE-BASED DESIGN OF NOVEL DIHYDROISOQUINOLINE BACE-1 INHIBITORS THAT DO NOT ENGAGE THE CATALYTIC ASPARTATES
4I10A:STRUCTURE-BASED DESIGN OF NOVEL DIHYDROISOQUINOLINE BACE-1 INHIBITORS THAT DO NOT ENGAGE THE CATALYTIC ASPARTATES
4I11A:STRUCTURE-BASED DESIGN OF NOVEL DIHYDROISOQUINOLINE BACE-1 INHIBITORS THAT DO NOT ENGAGE THE CATALYTIC ASPARTATES.
4I12A:DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS
4I1CA:DESIGN AND SYNTHESIS OF THIOPHENE DIHYDROISOQUINOLINS AS NOVEL BACE-1 INHIBITORS
4IVSA:CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR
4IVTA:CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR
4J0PA:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((S)-2-AMINO-4-METHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE
4J0TA:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-ETHOXY-PYRIDINE-2-CARBOXYLIC ACID [3-((R)-2-AMINO-5,5-DIFLUORO-4-METHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE
4J0VA:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4R,5R)-2-AMINO-5-FLUORO-4-METHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE
4J0YA:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4R,5S)-2-AMINO-5-FLUORO-4-METHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE
4J0ZA:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4S,5R)-2-AMINO-5-FLUORO-4-FLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE
4J17A:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((S)-2-AMINO-4-DIFLUOROMETHYL-5,6-DIHYDRO-4H-[1, 3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE
4J1CA:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((S)-2-AMINO-5,5-DIFLUORO-4-FLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE
4J1EA:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4S,6S)-2-AMINO-4-FLUOROMETHYL-6-TRIFLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE
4J1FA:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4S,6S)-2-AMINO-4-METHYL-6-TRIFLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE
4J1HA:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4S,6R)-2-AMINO-4-METHYL-6-TRIFLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE
4J1IA:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4R,5R,6R)-2-AMINO-5-FLUORO-4-METHYL-6-TRIFLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE
4J1KA:CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4R,5R,6S)-2-AMINO-5-FLUORO-4-METHYL-6-TRIFLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE
4JP9A:SPIROCYCLIC BETA-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1 (BACE1) INHIBITORS
4JPCA:SPIROCYCLIC BETA-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1 (BACE1) INHIBITORS
4JPEA:SPIROCYCLIC BETA-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1 (BACE1) INHIBITORS
4K8SA:; B:; C:HYDROXYETHYLAMINE-BASED INHIBITORS OF BACE1: P1-P3 MACROCYCLIZATION CAN IMPROVE POTENCY, SELECTIVITY, AND CELL ACTIVITY
4K9HA:; B:; C:BACE-1 INHIBITOR COMPLEX
4KE0A:; B:; C:CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH HYDROXYETHYLAMINE-MACROCYCLIC INHIBITOR 13
4KE1A:CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH HYDROXYETHYLAMINE-MACROCYCLIC INHIBITOR 19
4L7GA:DIETHYLAMINOSULFUR TRIFLUORIDE-MEDIATED INTRAMOLECULAR CYCLIZATION OF 2-HYDROXY-BENZYLUREAS TO FUSED BICYCLIC AMINOOXAZOLINE COMPOUNDS AND EVALUATION OF THEIR BIOCHEMICAL ACTIVITY AGAINST BETA-SECRETASE-1 (BACE1)
4L7HA:DIETHYLAMINOSULFUR TRIFLUORIDE-MEDIATED INTRAMOLECULAR CYCLIZATION OF 2-HYDROXY-BENZYLUREAS TO FUSED BICYCLIC AMINOOXAZOLINE COMPOUNDS AND EVALUATION OF THEIR BIOCHEMICAL ACTIVITY AGAINST BETA-SECRETASE-1 (BACE-1)
4L7JA:DIETHYLAMINOSULFUR TRIFLUORIDE-MEDIATED INTRAMOLECULAR CYCLIZATION OF 2-HYDROXY-BENZYLUREAS TO FUSED BICYCLIC AMINOOXAZOLINE COMPOUNDS AND EVALUATION OF THEIR BIOCHEMICAL ACTIVITY AGAINST BETA-SECRETASE-1 (BACE-1)
4LC7A:AMINOOXAZOLINE INHIBITOR OF BACE-1
4LXAA:; B:; C:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH COMPOUND 11A
4LXKA:; B:; C:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH COMPOUND 11D
4LXMA:; B:; C:CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH COMPOUND 12A
(-)
Protein domain: Cathepsin D (3)
(-)
Human (Homo sapiens) [TaxId: 9606] (3)
1LYAA:,B:; C:,D:CRYSTAL STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN D: IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN
1LYBA:,B:; C:,D:CRYSTAL STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN D: IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN
1LYWA:,B:; C:,D:; E:,F:; G:,H:CATHEPSIN D AT PH 7.5
(-)
Protein domain: Chymosin (synonym: renin) (67)
(-)
Cow (Bos taurus) [TaxId: 9913] (6)
1CMSA:THE THREE-DIMENSIONAL STRUCTURE OF RECOMBINANT BOVINE CHYMOSIN AT 2.3 ANGSTROMS RESOLUTION
1CZIE:CHYMOSIN COMPLEX WITH THE INHIBITOR CP-113972
3CMSA:ENGINEERING ENZYME SUB-SITE SPECIFICITY: PREPARATION, KINETIC CHARACTERIZATION AND X-RAY ANALYSIS AT 2.0-ANGSTROMS RESOLUTION OF VAL111PHE SITE-MUTATED CALF CHYMOSIN
4AA8A:BOVINE CHYMOSIN AT 1.8A RESOLUTION
4AUCA:BOVINE CHYMOSIN IN COMPLEX WITH PEPSTATIN A
4CMSA:X-RAY ANALYSES OF ASPARTIC PROTEINASES IV. STRUCTURE AND REFINEMENT AT 2.2 ANGSTROMS RESOLUTION OF BOVINE CHYMOSIN
(-)
Human (Homo sapiens) [TaxId: 9606] (60)
1BBSA:; B:X-RAY ANALYSES OF PEPTIDE INHIBITOR COMPLEXES DEFINE THE STRUCTURAL BASIS OF SPECIFICITY FOR HUMAN AND MOUSE RENINS
1BILA:; B:CRYSTALLOGRAPHIC STUDIES ON THE BINDING MODES OF P2-P3 BUTANEDIAMIDE RENIN INHIBITORS
1BIMA:; B:CRYSTALLOGRAPHIC STUDIES ON THE BINDING MODES OF P2-P3 BUTANEDIAMIDE RENIN INHIBITORS
1HRNA:; B:HIGH RESOLUTION CRYSTAL STRUCTURES OF RECOMBINANT HUMAN RENIN IN COMPLEX WITH POLYHYDROXYMONOAMIDE INHIBITORS
1RNEA:THE CRYSTAL STRUCTURE OF RECOMBINANT GLYCOSYLATED HUMAN RENIN ALONE AND IN COMPLEX WITH A TRANSITION STATE ANALOG INHIBITOR
2BKSA:; B:CRYSTAL STRUCTURE OF RENIN-PF00074777 COMPLEX
2BKTA:; B:CRYSTAL STRUCTURE OF RENIN-PF00257567 COMPLEX
2FS4A:; B:KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C RING
2G1NA:; B:KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING
2G1OA:; B:KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING
2G1RA:; B:KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C RING
2G1SA:; B:KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C RING
2G1YA:; B:KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING
2G20A:; B:KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C RING
2G21A:; B:KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING
2G22A:; B:KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING
2G24A:; B:KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING
2G26A:; B:KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING
2G27A:; B:KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING
2I4QA:; B:HUMAN RENIN/PF02342674 COMPLEX
2IKOA:; B:CRYSTAL STRUCTURE OF HUMAN RENIN COMPLEXED WITH INHIBITOR
2IKUA:; B:CRYSTAL STRUCTURE OF HUMAN RENIN COMPLEXED WITH INHIBITORS
2IL2A:; B:CRYSTAL STRUCTURE OF HUMAN RENIN COMPLEXED WITH INHIBITOR
2RENA:STRUCTURE OF RECOMBINANT HUMAN RENIN, A TARGET FOR CARDIOVASCULAR-ACTIVE DRUGS, AT 2.5 ANGSTROMS RESOLUTION
2V0ZC:; O:CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 10 (ALISKIREN)
2V10C:; O:CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 9
2V11C:; O:CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 6
2V13A:CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 7
2V16C:; O:CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 3
3D91A:; B:HUMAN RENIN IN COMPLEX WITH REMIKIREN
3G6ZA:; B:DESIGN AND PREPARATION OF POTENT, NON-PEPTIDIC, BIOAVAILABLE RENIN INHIBITORS
3G70A:; B:DESIGN AND PREPARATION OF POTENT, NON-PEPTIDIC, BIOAVAILABLE RENIN INHIBITORS
3G72A:; B:DESIGN AND PREPARATION OF POTENT, NON-PEPTIDIC, BIOAVAILABLE RENIN INHIBITORS
3GW5A:; B:CRYSTAL STRUCTURE OF HUMAN RENIN COMPLEXED WITH A NOVEL INHIBITOR
3K1WA:; B:NEW CLASSES OF POTENT AND BIOAVAILABLE HUMAN RENIN INHIBITORS
3KM4A:; B:OPTIMIZATION OF ORALLY BIOAVAILABLE ALKYL AMINE RENIN INHIBITORS
3OOTA:; B:CRYSTAL STRUCTURE ANALYSIS OF RENIN-INDOLE-PIPERAZIN INHIBITOR COMPLEXES
3OQFA:; B:CRYSTAL STRUCTURE ANALYSIS OF RENIN-INDOLE-PIPERAZINE INHIBITOR COMPLEXES
3OQKA:; B:CRYSTAL STRUCTURE ANALYSIS OF RENIN-INDOLE-PIPERAZIN INHIBITOR COMPLEXES
3OWNA:; B:POTENT MACROCYCLIC RENIN INHIBITORS
3Q3TA:; B:ALKYL AMINE RENIN INHIBITORS: FILLING S1 FROM S3
3Q4BA:; B:CLINICALLY USEFUL ALKYL AMINE RENIN INHIBITORS
3Q5HA:; B:CLINICALLY USEFUL ALKYL AMINE RENIN INHIBITORS
3SFCA:; B:STRUCTURE-BASED OPTIMIZATION OF POTENT 4- AND 6-AZAINDOLE-3-CARBOXAMIDES AS RENIN INHIBITORS
3VCMA:; B:CRYSTAL STRUCTURE OF HUMAN PRORENIN
3VSWA:; B:HUMAN RENIN IN COMPLEX WITH COMPOUND 8
3VSXA:; B:HUMAN RENIN IN COMPLEX WITH COMPOUND 18
3VUCA:; B:HUMAN RENIN IN COMPLEX WITH COMPOUND 5
3VYDA:; B:HUMAN RENIN IN COMPLEX WITH INHIBITOR 6
3VYEA:; B:HUMAN RENIN IN COMPLEX WITH INHIBITOR 7
3VYFA:; B:HUMAN RENIN IN COMPLEX WITH INHIBITOR 9
4GJ5A:; B:CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH NVP-AMQ838 (COMPOUND 5)
4GJ6A:; B:CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH NVP-AYZ832 (COMPOUND 6A)
4GJ7A:; B:CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH NVP-BCA079 (COMPOUND 12A)
4GJ8A:; B:CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH PKF909-724 (COMPOUND 3)
4GJ9A:; B:CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH GP055321 (COMPOUND 4)
4GJAA:; B:CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH NVP-AYL747 (COMPOUND 5)
4GJBA:; B:CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH NVP-BBV031 (COMPOUND 6)
4GJCA:; B:CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH NVP-BCH965 (COMPOUND 9)
4GJDA:; B:CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH NVP-BGQ311 (COMPOUND 12)
(-)
Mouse (Mus musculus) [TaxId: 10090] (1)
1SMRA:; C:; E:; G:THE 3-D STRUCTURE OF MOUSE SUBMAXILLARY RENIN COMPLEXED WITH A DECAPEPTIDE INHIBITOR CH-66 BASED ON THE 4-16 FRAGMENT OF RAT ANGIOTENSINOGEN
(-)
Protein domain: Endothiapepsin (46)
(-)
Chestnut blight fungus (Endothia parasitica) [TaxId: 5116] (46)
1E5OE:ENDOTHIAPEPSIN COMPLEX WITH INHIBITOR DB2
1E80E:ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD56133
1E81E:ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD61395
1E82E:ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD59601
1EEDP:X-RAY CRYSTALLOGRAPHIC ANALYSIS OF INHIBITION OF ENDOTHIAPEPSIN BY CYCLOHEXYL RENIN INHIBITORS
1ENTE:X-RAY ANALYSES OF ASPARTIC PROTEINASES. THE THREE-DIMENSIONAL STRUCTURE AT 2.1 ANGSTROMS RESOLUTION OF ENDOTHIAPEPSIN
1EPLE:A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA
1EPME:A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA
1EPNE:A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA
1EPOE:ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH CP-81,282 (MOR PHE NLE CHF NME)
1EPPE:ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-130, 693 (MAS PHE LYS+MTF STA MBA)
1EPQE:ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-133, 450 (SOT PHE GLY+SCC GCL)
1EPRE:ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-135, 040
1ER8E:THE ACTIVE SITE OF ASPARTIC PROTEINASES
1GKTA:NEUTRON LAUE DIFFRACTION STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH TRANSITION STATE ANALOGUE INHIBITOR H261
1GVTA:ENDOTHIAPEPSIN COMPLEX WITH CP-80,794
1GVUA:ENDOTHIAPEPSIN COMPLEX WITH H189
1GVVA:FIVE ATOMIC RESOLUTION STRUCTURES OF ENDOTHIAPEPSIN INHIBITOR COMPLEXES; IMPLICATIONS FOR THE ASPARTIC PROTEINASE MECHANISM
1GVWA:ENDOTHIAPEPSIN COMPLEX WITH PD-130,328
1GVXA:ENDOTHIAPEPSIN COMPLEXED WITH H256
1OD1A:ENDOTHIAPEPSIN PD135,040 COMPLEX
1OEWA:ATOMIC RESOLUTION STRUCTURE OF NATIVE ENDOTHIAPEPSIN
1OEXA:ATOMIC RESOLUTION STRUCTURE OF ENDOTHIAPEPSIN IN COMPLEX WITH A HYDROXYETHYLENE TRANSITION STATE ANALOGUE INHIBITOR H261
2ER0E:X-RAY STUDIES OF ASPARTIC PROTEINASE-STATINE INHIBITOR COMPLEXES
2ER6E:THE STRUCTURE OF A SYNTHETIC PEPSIN INHIBITOR COMPLEXED WITH ENDOTHIAPEPSIN.
2ER7E:X-RAY ANALYSES OF ASPARTIC PROTEINASES.III. THREE-DIMENSIONAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH A TRANSITION-STATE ISOSTERE INHIBITOR OF RENIN AT 1.6 ANGSTROMS RESOLUTION
2ER9E:X-RAY STUDIES OF ASPARTIC PROTEINASE-STATINE INHIBITOR COMPLEXES.
3ER3E:THE ACTIVE SITE OF ASPARTIC PROTEINASES
3ER5E:THE ACTIVE SITE OF ASPARTIC PROTEINASES
3T6IA:ENDOTHIAPEPSIN IN COMPLEX WITH AN AZEPIN DERIVATIVE
3T7PA:ENDOTHIAPEPSIN IN COMPLEX WITH A HYDRAZIDE DERIVATIVE
3T7QA:ENDOTHIAPEPSIN IN COMPLEX WITH AN INHIBITOR BASED ON THE GEWALD REACTION
3T7XA:ENDOTHIAPEPSIN IN COMPLEX WITH AN INHIBITOR BASED ON THE GEWALD REACTION
3URIA:ENDOTHIAPEPSIN-DB5 COMPLEX.
3URJA:TYPE IV NATIVE ENDOTHIAPEPSIN
3URLA:ENDOTHIAPEPSIN-DB6 COMPLEX.
4APEA:THE ACTIVE SITE OF ASPARTIC PROTEINASES
4ER1E:THE ACTIVE SITE OF ASPARTIC PROTEINASES
4ER2E:THE ACTIVE SITE OF ASPARTIC PROTEINASES
4ER4E:HIGH-RESOLUTION X-RAY ANALYSES OF RENIN INHIBITOR-ASPARTIC PROTEINASE COMPLEXES
4KUPA:ENDOTHIAPEPSIN IN COMPLEX WITH 20MM ACYLHYDRAZONE INHIBITOR
4LBTA:ENDOTHIAPEPSIN IN COMPLEX WITH 100MM ACYLHYDRAZONE INHIBITOR
4LHHA:ENDOTHIAPEPSIN IN COMPLEX WITH 2MM ACYLHYDRAZONE INHIBITOR
4LP9A:ENDOTHIAPEPSIN COMPLEXED WITH PHE-REDUCED-TYR PEPTIDE.
5ER1E:A RATIONAL APPROACH TO THE DESIGN OF ANTIHYPERTENSIVES. X-RAY STUDIES OF COMPLEXES BETWEEN ASPARTIC PROTEINASES AND AMINOALCOHOL RENIN INHIBITORS
5ER2E:HIGH-RESOLUTION X-RAY DIFFRACTION STUDY OF THE COMPLEX BETWEEN ENDOTHIAPEPSIN AND AN OLIGOPEPTIDE INHIBITOR. THE ANALYSIS OF THE INHIBITOR BINDING AND DESCRIPTION OF THE RIGID BODY SHIFT IN THE ENZYME
(-)
Protein domain: Pepsin (1)
(-)
Mucor pusillus [TaxId: 4840] (1)
1MPPA:X-RAY ANALYSES OF ASPARTIC PROTEINASES. V. STRUCTURE AND REFINEMENT AT 2.0 ANGSTROMS RESOLUTION OF THE ASPARTIC PROTEINASE FROM MUCOR PUSILLUS
(-)
Protein domain: Pepsin(ogen) (16)
(-)
Atlantic cod (Gadus morhua) [TaxId: 8049] (1)
1AM5A:THE CRYSTAL STRUCTURE AND PROPOSED AMINO ACID SEQUENCE OF A PEPSIN FROM ATLANTIC COD (GADUS MORHUA)
(-)
Human (Homo sapiens), isoform 3A [TaxId: 9606] (5)
1FLHA:CRYSTAL STRUCTURE OF HUMAN UROPEPSIN AT 2.45 A RESOLUTION
1PSNA:THE CRYSTAL STRUCTURE OF HUMAN PEPSIN AND ITS COMPLEX WITH PEPSTATIN
1PSOE:THE CRYSTAL STRUCTURE OF HUMAN PEPSIN AND ITS COMPLEX WITH PEPSTATIN
1QRPE:HUMAN PEPSIN 3A IN COMPLEX WITH A PHOSPHONATE INHIBITOR IVA-VAL-VAL-LEU(P)-(O)PHE-ALA-ALA-OME
3UTLA:HUMAN PEPSIN 3B
(-)
Human (Homo sapiens), progastricsin (pepsinogen C) [TaxId: 9606] (2)
1AVFP:,A:; Q:,J:ACTIVATION INTERMEDIATE 2 OF HUMAN GASTRICSIN FROM HUMAN STOMACH
1HTRP:,B:CRYSTAL AND MOLECULAR STRUCTURES OF HUMAN PROGASTRICSIN AT 1.62 ANGSTROMS RESOLUTION
(-)
Pig (Sus scrofa) [TaxId: 9823] (8)
1F34A:CRYSTAL STRUCTURE OF ASCARIS PEPSIN INHIBITOR-3 BOUND TO PORCINE PEPSIN
1PSAA:; B:STRUCTURE OF A PEPSIN(SLASH)RENIN INHIBITOR COMPLEX REVEALS A NOVEL CRYSTAL PACKING INDUCED BY MINOR CHEMICAL ALTERATIONS IN THE INHIBITOR
1YX9A:EFFECT OF DIMETHYL SULPHOXIDE ON THE CRYSTAL STRUCTURE OF PORCINE PEPSIN
2PSGA:REFINED STRUCTURE OF PORCINE PEPSINOGEN AT 1.8 ANGSTROMS RESOLUTION
3PEPA:REVISED 2.3 ANGSTROMS STRUCTURE OF PORCINE PEPSIN. EVIDENCE FOR A FLEXIBLE SUBDOMAIN
3PSGA:THE HIGH RESOLUTION CRYSTAL STRUCTURE OF PORCINE PEPSINOGEN
4PEPA:THE MOLECULAR AND CRYSTAL STRUCTURES OF MONOCLINIC PORCINE PEPSIN REFINED AT 1.8 ANGSTROMS RESOLUTION
5PEPA:X-RAY ANALYSES OF ASPARTIC PROTEASES. II. THREE-DIMENSIONAL STRUCTURE OF THE HEXAGONAL CRYSTAL FORM OF PORCINE PEPSIN AT 2.3 ANGSTROMS RESOLUTION
(-)
Protein domain: Plant acid proteinase, phytepsin (2)
(-)
Barley (Hordeum vulgare) [TaxId: 4513] (1)
1QDMA:2-247,A:248-338; B:2-247,B:248-338; C:3-247,C:248-338CRYSTAL STRUCTURE OF PROPHYTEPSIN, A ZYMOGEN OF A BARLEY VACUOLAR ASPARTIC PROTEINASE.
(-)
Cynara cardunculus [TaxId: 4265] (1)
1B5FA:,B:; C:,D:NATIVE CARDOSIN A FROM CYNARA CARDUNCULUS L.
(-)
Protein domain: Plasmepsin (a hemoglobin-degrading enzyme) (21)
(-)
Plasmodium falciparum, plasmepsin II [TaxId: 5833] (18)
1LEEA:CRYSTAL STRUCTURE OF PLASMEPSIN FROM P. FALCIPARUM IN COMPLEX WITH INHIBITOR RS367
1LF2A:CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM IN COMPLEX WITH INHIBITOR RS370
1LF3A:CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM IN COMPLEX WITH INHIBITOR EH58
1LF4A:STRUCTURE OF PLASMEPSIN II
1M43A:; B:CRYSTAL STRUCTURE OF PMII IN COMPLEX WITH PEPSTATIN A TO 2.4 A
1ME6A:; B:CRYSTAL STRUCTURE OF PLASMEPSIN II, AN ASPARTYL PROTEASE FROM PLASMODIUM FALCIPARUM, IN COMPLEX WITH A STATINE-BASED INHIBITOR
1PFZA:; B:; C:; D:PROPLASMEPSIN II FROM PLASMODIUM FALCIPARUM
1SMEA:; B:PLASMEPSIN II, A HEMOGLOBIN-DEGRADING ENZYME FROM PLASMODIUM FALCIPARUM, IN COMPLEX WITH PEPSTATIN A
1W6HA:; B:NOVEL PLASMEPSIN II-INHIBITOR COMPLEX
1W6IA:; C:PLASMEPSIN II-PEPSTATIN A COMPLEX
1XDHA:; B:STRUCTURE OF PLASMEPSIN II IN COMPLEX WITH PEPSTATIN A
1XE5A:; B:STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATIN ANALOGUE
1XE6A:; B:STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATIN ANALOGUE
2BJUA:1-329PLASMEPSIN II COMPLEXED WITH A HIGHLY ACTIVE ACHIRAL INHIBITOR
2IGXA:ACHIRAL, CHEAP AND POTENT INHIBITORS OF PLASMEPSINS II
2IGYA:; B:ACHIRAL, CHEAP AND POTENT INHIBITORS OF PLASMEPSINS II
2R9BA:; B:STRUCTURAL ANALYSIS OF PLASMEPSIN 2 FROM PLASMODIUM FALCIPARUM COMPLEXED WITH A PEPTIDE-BASED INHIBITOR
3F9QA:RE-REFINEMENT OF UNCOMPLEXED PLASMEPSIN II FROM PLASMODIUM FALCIPARUM.
(-)
Plasmodium falciparum, plasmepsin IV [TaxId: 5833] (1)
1LS5A:; B:CRYSTAL STRUCTURE OF PLASMEPSIN IV FROM P. FALCIPARUM IN COMPLEX WITH PEPSTATIN A
(-)
Plasmodium vivax [TaxId: 5855] (2)
1MIQA:; B:CRYSTAL STRUCTURE OF PROPLASMEPSIN FROM THE HUMAN MALARIAL PATHOGEN PLASMODIUM VIVAX
1QS8A:; B:CRYSTAL STRUCTURE OF THE P. VIVAX ASPARTIC PROTEINASE PLASMEPSIN COMPLEXED WITH THE INHIBITOR PEPSTATIN A
(-)
Protein domain: Xylanase inhibitor TAXI-I (4)
(-)
Wheat (Triticum aestivum) [TaxId: 4565] (4)
1T6EX:CRYSTAL STRUCTURE OF THE TRITICUM AESTIVUM XYLANASE INHIBITOR I
1T6GA:; B:CRYSTAL STRUCTURE OF THE TRITICUM AESTIVUM XYLANASE INHIBITOR-I IN COMPLEX WITH ASPERGILLUS NIGER XYLANASE-I
2B42A:1-381CRYSTAL STRUCTURE OF THE TRITICUM XYLANSE INHIBITOR-I IN COMPLEX WITH BACILLUS SUBTILIS XYLANASE
3HD8A:; C:CRYSTAL STRUCTURE OF THE TRITICUM AESTIVUM XYLANASE INHIBITOR-IIA IN COMPLEX WITH BACILLUS SUBTILIS XYLANASE